BREAKFAST SYMPOSIUM
Sunday, October 20, 2024 07:45 AM - 08:45 AM
Sponsored by
Navigating the Systemic Treatment Options for Advanced stage HCC.
A breakfast symposium where we will discuss the multidisciplinary management and selection of frontline systemic treatment options for patients with uHCC in Canada and delve into a number of patient cases where we will apply this knowledge to optimize outcomes for patients with uHCC.
Objectives:
- Appraise the need for the multidisciplinary management of patients with unresectable hepatocellular carcinoma (HCC)
- Evaluate the role of immunotherapy (IO) in the treatment of unresectable HCC and assess how to address safety concerns in patients initiating IO
- Describe how to optimize unresectable HCC treatment based on patient characteristics
SPEAKER: BRANDON M. MEYERS, MSc MD FRCP(C)
Dr. Meyers completed medical school at the University of Ottawa. He then completed at McMaster University post-graduate training in Internal Medicine, and Medical Oncology. A fellowship was completed in Gastrointestinal Malignancies.
He is an Associate Professor and staff Medical Oncologist at the Juravinski Cancer Centre, and Associate Member of the Escarpment Cancer Research Institute in Hamilton, Ontario. His gastrointestinal clinical practice primarily focuses on hepatocellular carcinoma.
He recently helped develop the Cancer Care Ontario guidelines on the management of advanced hepatocellular carcinoma, and is Co-Lead on Pathway Management for hepatocellular carcinoma. He is a chair of the Canadian Multidisciplinary HCC Conference.
LUNCH SYMPOSIUM
Sunday, October 20, 2024 12:15 PM to 1:15 PM
Sponsored by
Enhancing the Patient Journey: How to Improve Care for HCC Patients?
Objectives:
- Review the patient journey from hepatocellular carcinoma (HCC) diagnosis to treatment.
- Discuss holistic approaches to improving care for HCC patients, including improving quality of life.
- Describe how to optimize unresectable HCC treatment based on patient characteristics